TALZENNA® first PARP inhibitor to demonstrate clinical benefit in combination with XTANDI® in metastatic castration-resistant prostate cancer (mCRPC) Study achieves primary endpoint of radiographic progression-free survival Robust, highly consistent efficacy demonstrated in… Read More
TORONTO, ON — Bloom Burton & Co. (“Bloom Burton”) is pleased to announce Pieter Cullis, Co-Founder of Acuitas Therapeutics, as the recipient of the 2022 Bloom Burton Award. Pieter Cullis… Read More
Creating a stronger and more sustainable life sciences ecosystem in Canada OTTAWA, ON — In celebration of Global Biotech Week, today at the national BIONATION 2022 conference, the leaders of… Read More
Gold Leaf Awards Celebrate the Best in Canadian Biotech OTTAWA, ON – BIOTECanada is pleased to announce the 2022 winners in four BIOTECanada Gold Leaf Award categories- Established Biotech Company… Read More
CO2 footprint reduction of 30% supports tire industry customers achieve sustainability ambitions Collaboration is first step towards biobased silica and meeting growing demand for renewable raw materials New plant commissioning expected… Read More
